Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2026 06:05 ET | Quelle: Research and Markets

$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CXO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Biopharmaceutical CXO...
09. April 2026 06:00 ET | Quelle: Zymeworks Inc.

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

• Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc....
09. April 2026 04:44 ET | Quelle: Research and Markets

Biopharmaceutical CMO & CRO (Analytical, Cell Culture, Clinical Development, Fill-Finish, Formulation, Preclinical Development, Process Development) Market Research & Global Forecast Report 2026-2032

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
09. April 2026 04:34 ET | Quelle: LEADS BIOLABS CO., LTD.

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibody,
09. April 2026 04:03 ET | Quelle: Research and Markets

Artificial Intelligence in Pharmaceutical Market Research and Global Forecast Report 2026-2032

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Pharmaceutical Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
09. April 2026 04:00 ET | Quelle: BDC

BDC launches a $150‑million Life Sciences Venture Fund

MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) -- The Business Development Bank of Canada (BDC) today announced the launch of its $150‑million Life Sciences Venture Fund, created to support the next...
09. April 2026 02:00 ET | Quelle: Trogenix

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...
09. April 2026 01:00 ET | Quelle: Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference

Vivoryon attend the Van Lanschot Kempen Life Sciences Conference.
09. April 2026 00:30 ET | Quelle: Custom Market Insights

Global Centrifugal High-Speed Separators Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Centrifugal High-Speed Separators Market Size, Trends and Insights By Type...
08. April 2026 20:04 ET | Quelle: Robbins LLP

MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action lawsuit Filed Against Medpace Holdings Inc.

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio

Vorherige Seite

Nächste Seite